Three Drugs in Advanced Gastric Cancer Neoadjuvant Chemotherapy for Stage Ⅲ Multicenter, Open, Randomized, Controlled Clinical Study

NCT02555358 Phase 2 COMPLETED

The purpose of this study is to assess the relationship of pCR rate and efficacy by comparing the two drugs and three drugs as neoadjuvant chemotherapy in advanced gastric cancer patients.

Details

Lead sponsor	Qun Zhao
Phase	Phase 2
Status	COMPLETED
Enrolment	300
Start date	2014-11
Completion	2022-06

Conditions

• Gastric Cancer

Interventions

• docetaxel,0xaliplatin,capecitabine
• oxaliplatin,capecitabine

Primary outcomes

• The pathological complete response rate — 24 weeks

Countries

China